Skip to main content
MLSS logo

MLSS · Milestone Scientific Inc. · Earnings Call Transcripts & Audio

Track MLSS — free
$0.44 +0.01 (+2.28%) At close · Sep 11
Market Cap
$39.40M
Shares
88.74M

Milestone Scientific Inc. Earnings Call Transcripts

Quarterly earnings calls for Milestone Scientific Inc. (MLSS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Earnings call
FY26 · Q1
2026-03-31
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript
Confident tone Medicare Reimbursement CompuFlo Medical Growth Dental Ambassador Program
Revenue
$2.16M
▼ 3.2% YoY
Diluted EPS
$-0.01
Gross margin
72.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-12-31
Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript
Confident tone Dental business (STA) and Ambassador program CompuFlo commercialization and pain clinic focus 2026 financial guidance
Revenue
$2.06M*
▲ 2.2% YoY
Gross margin
73.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Milestone Scientific Inc. (MLSS) Q3 2025 Earnings Call Transcript
Positive tone CompuFlo and reimbursement strategy Revenue stability Cost reduction and operational restructuring
Revenue
$2.36M
▼ 6.1% YoY
Diluted EPS
$-0.01
Gross margin
69.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript
Positive tone CompuFlo Epidural System Commercialization Medicare Reimbursement and JMAC Expansion Strategic Partnership with Axial Biologics
Revenue
$2.51M
▲ 22.1% YoY
Diluted EPS
$-0.02
Gross margin
73.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Milestone Scientific Inc. (MLSS) Q2 2024 Earnings Call Transcript
Confident tone Near-term revenue timing and guidance discipline Commercial rollout strategy via Axial Biologics partnership Dental division e-commerce transition and gross margins
Revenue
$1.85M
▼ 36.3% YoY
Gross margin
76.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript
Positive tone Peripheral nerve block and next-generation pipeline Dental direct sales strategy and e-commerce growth Hospital approval and sales cycle friction
Revenue
$2.25M
▼ 13.4% YoY
Gross margin
74.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Milestone Scientific Inc. (MLSS) Q4 2023 Earnings Call Transcript
Revenue
$2.26M*
▲ 0.9% YoY
Gross margin
66.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Milestone Scientific Inc. (MLSS) Q3 2023 Earnings Call Transcript
Revenue
$2.06M
▼ 7.1% YoY
Gross margin
73.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Milestone Scientific Inc. (MLSS) Q2 2023 Earnings Call Transcript
Revenue
$2.91M
▲ 76.5% YoY
Gross margin
65.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Milestone Scientific Inc. (MLSS) Q1 2023 Earnings Call Transcript
Revenue
$2.60M
▼ 3.8% YoY
Gross margin
72.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Milestone Scientific Inc. (MLSS) Q4 2022 Earnings Call Transcript
Revenue
$2.24M*
▼ 21.3% YoY
Gross margin
48.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Milestone Scientific Inc. (MLSS) Q3 2022 Earnings Call Transcript
Revenue
$2.22M
▲ 5.1% YoY
Diluted EPS
$-0.03
Gross margin
65.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Milestone Scientific Inc. (MLSS) Q2 2022 Earnings Call Transcript
Revenue
$1.65M
▼ 32% YoY
Diluted EPS
$-0.04
Gross margin
41.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Milestone Scientific Inc. (MLSS) Q1 2022 Earnings Call Transcript
Revenue
$2.70M
▼ 7.7% YoY
Diluted EPS
$-0.03
Gross margin
62.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Milestone Scientific Inc. (MLSS) Q4 2021 Earnings Call Transcript
Revenue
$2.85M*
▲ 28.7% YoY
Gross margin
62.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Milestone Scientific Inc. (MLSS) Q3 2021 Earnings Call Transcript
Revenue
$2.11M
▲ 69.2% YoY
Diluted EPS
$-0.03
Gross margin
64.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Milestone Scientific Inc. (MLSS) Q2 2021 Earnings Call Transcript
Revenue
$2.43M
▲ 1346.7% YoY
Diluted EPS
$-0.04
Gross margin
56.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Milestone Scientific Inc. (MLSS) Q1 2021 Earnings Call Transcript
Revenue
$2.92M
▲ 61.5% YoY
Diluted EPS
$-0.01
Gross margin
61.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Milestone Scientific Inc. (MLSS) Q4 2020 Earnings Call Transcript
Revenue
$2.21M*
▼ 3.9% YoY
Gross margin
62.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Milestone Scientific Inc. (MLSS) Q3 2020 Earnings Call Transcript
Revenue
$1.25M
▼ 34.4% YoY
Diluted EPS
$-0.02
Gross margin
67.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Milestone Scientific Inc. (MLSS) Q2 2020 Earnings Call Transcript
Revenue
$167,674
▼ 92.6% YoY
Diluted EPS
$-0.06
Gross margin
66.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Milestone Scientific Inc. (MLSS) Q1 2020 Earnings Call Transcript
Revenue
$1.81M
▼ 5.5% YoY
Diluted EPS
$-0.03
Gross margin
70.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–22 of 22 earnings calls
Key facts CIK 855683 CUSIP 59935P209 13F (30d) 5 filings 5 filers Visit website